Phase 3 Data Support CT-155 as a Novel Digital Therapeutic for Negative Symptoms in Schizophrenia at ECNP
Data from the CONVOKE study showcased positive results with CT-155, a digital therapeutic for treatment of negative symptoms in…
Research Recap From the European College of Neuropsychopharmacology Congress
